Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review

Abstract

For patients with advanced ESCC, ICIs are more effective and safer than chemotherapy, and thus have a higher treatment value.